◆英語タイトル:ERBA Molecular Ltd - Product Pipeline Analysis, 2018 Update
◆商品コード:DATA904C12751
◆発行会社(調査会社):
GlobalData
◆発行日:2018年12月
◆ページ数:29
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:医療機器
◆販売価格オプション(消費税別)
※
販売価格オプションの説明はこちらで、
ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※
GlobalData社の概要はこちらでご確認いただけます。
【レポートの概要】
Summary
ERBA Molecular Ltd (ERBA Molecular), formerly Lumora Ltd, a subsidiary of Erba Diagnostics Mannheim GmbH, is a medical equipment company that offers innovative molecular diagnostics. The company provides technology that is used in medical diagnostics, agricultural, livestock and crops, food safety and pharmaceutical testing equipment, veterinary care products and personal care products. It also provides malaria diagnostic assay for screening patients, in-vitro diagnostics, and others. ERBA Molecular offers services such as bioinformatics, lyophilisation, testing, sample preparation, assay optimization, primer screening, commercial assay design programs, additional project support, and molecular test development process, among others. The company provides its products and services through its distributors located across the UK. ERBA Molecular is headquartered in Ely, the UK.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company ERBA Molecular Ltd
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
ERBA Molecular Ltd Company Overview 4
ERBA Molecular Ltd Company Snapshot 4
ERBA Molecular Ltd Pipeline Products and Ongoing Clinical Trials Overview 4
ERBA Molecular Ltd – Pipeline Analysis Overview 7
ERBA Molecular Ltd – Key Facts 7
ERBA Molecular Ltd – Major Products and Services 8
ERBA Molecular Ltd Pipeline Products by Development Stage 9
ERBA Molecular Ltd Pipeline Products Overview 11
BART – HIV Viral Load Test 11
BART – HIV Viral Load Test Product Overview 11
Diagnostic Test – Campylobacter 12
Diagnostic Test – Campylobacter Product Overview 12
Diagnostic Test – E. coli 0157 13
Diagnostic Test – E. coli 0157 Product Overview 13
Diagnostic Test – H. Pylori 14
Diagnostic Test – H. Pylori Product Overview 14
Diagnostic Test – MRSA 15
Diagnostic Test – MRSA Product Overview 15
Diagnostic Test – Noro Virus 16
Diagnostic Test – Noro Virus Product Overview 16
Diagnostic Test – Salmonella 17
Diagnostic Test – Salmonella Product Overview 17
Early Infant Diagnostic Assay – HIV 18
Early Infant Diagnostic Assay – HIV Product Overview 18
Next Generation Fully Integrated Device 19
Next Generation Fully Integrated Device Product Overview 19
Next Generation HIV Viral Load Monitoring Test 20
Next Generation HIV Viral Load Monitoring Test Product Overview 20
Screening Assay – Malaria 21
Screening Assay – Malaria Product Overview 21
ERBA Molecular Ltd – Key Competitors 22
ERBA Molecular Ltd – Key Employees 23
ERBA Molecular Ltd – Locations And Subsidiaries 24
Head Office 24
Recent Developments 25
ERBA Molecular Ltd, Recent Developments 25
Feb 17, 2014: UNITAID Report Highlights Lumora’s Technology for Viral Load Monitoring for HIV 25
Appendix 26
Methodology 26
About GlobalData 29
Contact Us 29
Disclaimer 29
List of Tables
ERBA Molecular Ltd Pipeline Products and Ongoing Clinical Trials Overview 4
ERBA Molecular Ltd Pipeline Products by Equipment Type 5
ERBA Molecular Ltd Pipeline Products by Indication 6
ERBA Molecular Ltd, Key Facts 7
ERBA Molecular Ltd, Major Products and Services 8
ERBA Molecular Ltd Number of Pipeline Products by Development Stage 9
ERBA Molecular Ltd Pipeline Products Summary by Development Stage 10
BART - HIV Viral Load Test - Product Status 11
BART - HIV Viral Load Test - Product Description 11
Diagnostic Test - Campylobacter - Product Status 12
Diagnostic Test - Campylobacter - Product Description 12
Diagnostic Test - E. coli 0157 - Product Status 13
Diagnostic Test - E. coli 0157 - Product Description 13
Diagnostic Test - H. Pylori - Product Status 14
Diagnostic Test - H. Pylori - Product Description 14
Diagnostic Test - MRSA - Product Status 15
Diagnostic Test - MRSA - Product Description 15
Diagnostic Test - Noro Virus - Product Status 16
Diagnostic Test - Noro Virus - Product Description 16
Diagnostic Test - Salmonella - Product Status 17
Diagnostic Test - Salmonella - Product Description 17
Early Infant Diagnostic Assay - HIV - Product Status 18
Early Infant Diagnostic Assay - HIV - Product Description 18
Next Generation Fully Integrated Device - Product Status 19
Next Generation Fully Integrated Device - Product Description 19
Next Generation HIV Viral Load Monitoring Test - Product Status 20
Next Generation HIV Viral Load Monitoring Test - Product Description 20
Screening Assay - Malaria - Product Status 21
Screening Assay - Malaria - Product Description 21
ERBA Molecular Ltd, Key Employees 23
Glossary 28
List of Figures
ERBA Molecular Ltd Pipeline Products by Equipment Type 5
ERBA Molecular Ltd Pipeline Products by Development Stage 9